UW Health and University of Wisconsin to test new COVID-19 vaccine


UW Health and the University of Wisconsin will become one of the first sites in the country to study whether a new vaccine can prevent COVID-19.

In a news release Monday, UW Health announced the upcoming study of an investigational vaccine developed by the pharmaceutical company AstraZeneca.

“Our entire team has been working diligently for months to bring this important clinical trial to our state, and now Wisconsinites have an opportunity to be part of solving this crisis,” said Betsy Nugent, chief clinical research officer at UW Health and School of Medicine and Public Health.

The study, which is currently recruiting participants, is a phase 3 randomized, double-blinded, placebo-controlled clinical trial. It is considered the “gold standard for measuring the efficacy of investigatory drugs.”

UW is one of 100 clinical sites around the country to participate in the trial and will enroll about 1,600 people through Oct. at University Hospital. Read more …